Nucleic Acids Research, 1983, Vol. 11, No. 15 5093-5102
© 1983
MOLECULAR BIOLOGY |
Site-specific modification of the lactose operator with acetylaminofluorene
*Department of Chemical Carcinogenesis, Sloan-Kettering Institute for Cancer Research Rye, NY 10580, USA +BioLogicals Ottawa, K1Y 4P1 Canada
Received June 3, 1983. Revised July 4, 1983. Accepted July 4, 1983.
We have synthesized the tetradecamer GAGCXGATAACAAG containing a part of the sequence of the lactose operator. A guanine base in the sequence is replaced by the adduct of the carcinogen 2-acetylaminofluorene with guanine. Under the standard conditions of de-protection, the fluorene moiety is lost, leaving behind a guanine oxidation product. New conditions of de-protection have been developed which allow the isolation of an oligonucleotide containing the adduct of 2-aminofluorene with guanine. The presence of the amino-fluorene adduct greatly increases retention on reverse phase chromatography and produces a unique pattern of sequencing bands.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. C. J. Gillet, J. Alzeer, and O. D. Scharer Site-specific incorporation of N-(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG-AAF) into oligonucleotides using modified 'ultra-mild' DNA synthesis Nucleic Acids Res., April 6, 2005; 33(6): 1961 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Torres, C. V. Varaprasad, F. Johnson, and C. R. Iden Formation of s-triazines during aerial oxidation of 8-oxo-7,8-dihydro-2'-deoxyguanosine in concentrated ammonia Carcinogenesis, January 1, 1999; 20(1): 167 - 172. [Abstract] [Full Text] [PDF] |
||||

